Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Leukemia, Plasma Cell 1Gliosarcoma 1Glioma 1Glioblastoma 1

Interventions

fludarabine 4Lenalidomide 4Cyclophosphamide 4fludarabine phosphate 3Whole-Body Irradiation 3Dexamethasone 3Sirolimus 2Mycophenolic Acid 2venetoclax 1sargramostim 1plerixafor 1pegylated granulocyte colony-stimulating factor 1montanide ISA 51 1itacitinib 1isatuximab 1incomplete Freund's adjuvant 1ferric pyrophosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1auricularum 1Stem Cell Transplantation 1Specimen Handling 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Magnetic Resonance Spectroscopy 1Hyaluronoglucosaminidase 1High-Throughput Screening Assays 1Hematopoietic Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Plasma Cell × ferric pyrophosphate × 1 year × Clear all
NCT07605416 2026-05-26

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
74 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡